- Provide up to date assessment of current knowledge regarding the infections and other clinical problems associated with impaired or delayed immune reconstitution following an allogeneic hematopoietic cell transplant administered for a lethal genetic immune deficiency or a hematologic malignancy or marrow failure syndrome.
- Present current knowledge regarding the cellular interactions between donor hematopoietic and lymphoid cells and the tissues and Thymus of the transplanted host that influences the kinetics and qualities of reconstitution of cell mediated and antibody-based immunity.
- Present current results of new therapeutic approaches including cytokines, drugs and cellular therapies to accelerate or compensate for immune deficiencies in the post transplant period associated with high risk of lethal infection and/or disease relapse.
This conference should be of value to MD’s, PhD’s, DO’s, PA’s, NP’s, RN’s, allied medical professionals.
Memorial Sloan-Kettering Cancer is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Memorial Sloan-Kettering Cancer Center designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.